市場調査レポート

商品コード

1401969

ホルモン補充療法市場の2030年までの予測：治療タイプ別、投与経路別、適応症別、流通チャネル別、地域別の世界分析

Hormone Replacement Therapy Market Forecasts to 2030 - Global Analysis By Therapy Type, By Route of Administration, Indication, Distribution Channel and By Geography

出版日: 2023年12月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 652,131円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 824,985円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 997,839円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,178,550円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界のホルモン補充療法市場は2023年に358億米ドルを占め、予測期間中のCAGRは8.2％で成長し、2030年には621億米ドルに達する見込みです。

ホルモン補充療法（HRT）には、加齢や更年期障害、その他の疾患によってホルモンバランスが崩れている人に対し、エストロゲン、プロゲステロン、テストステロンなどのホルモンを補充・置換することを目的とした医療行為が含まれます。HRTは、女性ではほてり、気分の落ち込み、膣の乾燥などの症状を緩和し、男性ではホルモン不足に対処することができます。

世界保健機関（WHO）によると、2030年までに世界全体で6人に1人が60歳以上の高齢者となり、2050年までに老年人口は21億人に達すると推定されています。

多様なホルモン障害の有病率の増加

多様なホルモン障害の有病率の増加は、ホルモン補充療法市場の重要な促進要因となっています。人口の高齢化、ライフスタイルの変化、環境の影響などの要因は、ホルモンバランスの乱れ、女性の更年期関連症状、男性のandropauseの発生率の上昇に寄与しています。甲状腺機能低下症、更年期障害、ホルモン欠乏症などの症状が、HRTの需要を押し上げています。ホルモン障害に関連する症状や合併症の緩和を求める患者が増加していることが、ホルモン補充療法市場の拡大を後押ししています。

ホルモン補充療法の高コスト

ホルモン補充療法の薬代、診察代、経過観察にかかる費用は高額になることがあり、多くの患者の経済的負担に影響を与えています。さらに、保険適用や償還の制限により、しばしば自己負担が生じ、利用しやすさが制限されます。このような経済的障壁は、ホルモン補充療法を希望したり継続したりすることを躊躇させ、治療のアドヒアランスと市場全体の成長に影響を及ぼす可能性があります。

新規デリバリー・システムによる薬剤開発の増加

経皮パッチ、皮下インプラント、生分解性ミクロスフェアなどの革新的な送達方法は、治療効果、患者のコンプライアンス、利便性を高めます。これらの進歩は、従来の経口製剤に比べ、正確な投与、安定したホルモン放出、副作用の軽減をもたらします。また、治療成績を改善し、ホルモン補充療法を求める個人の多様なニーズに対応することで、患者の関心を集め、治療の選択肢を広げ、市場の成長を促進しています。

治療による副作用

ホルモン療法、特にエストロゲンベースのものは、血栓、脳卒中、乳がん、心血管合併症のリスクを高める可能性があります。これらのリスクは、年齢、投与量、治療期間、個人の健康歴などの要因によって異なります。こうした副作用への懸念からHRTの使用量は減少し、長期的な安全性についても疑問が呈されており、市場の成長に影響を与えています。

COVID-19の影響：

COVID-19の大流行は市場にさまざまな影響を与えました。診療所へのアクセス制限や選択的手術の減少などヘルスケアサービスの混乱は、HRTの処方や患者の診察に影響を与えました。健康上の懸念が高まったため、ホルモン療法を受けるのが遅れました。しかし、パンデミックの間に更年期症状や精神的健康問題に対する認識が高まったことが、HRTの需要を促進した可能性があります。

予測期間中、更年期セグメントが最大となる見込み

予測期間中、更年期セグメントが市場最大になると予想されます。人口の高齢化に伴い、閉経を迎える女性の数が増加し、ほてり、寝汗、気分の変化などの更年期症状を管理する治療法を求める層が増加します。さらに、更年期症状に特化したHRT製剤や投与方法の進歩が、この分野の成長に寄与しています。

予測期間中、ヒト成長ホルモン補充療法分野のCAGRが最も高くなる見込み

予測期間中、ヒト成長ホルモン（HGH）補充療法分野は、成長ホルモン欠乏症に対する認識の高まりに加え、成人および小児におけるホルモンバランスの乱れが増加し、HGH療法の需要を牽引していることから、堅調な成長が見込まれます。さらに、革新的なHGH製剤と送達方法の開発につながるバイオテクノロジーの主な発展が、さまざまな健康状態への対処における用途の拡大とともに、この分野の大幅な成長を予測する主な要因となっています。

最大のシェアを持つ地域：

北米は、先進的なヘルスケア・インフラ、高い医療費、研究開発に重点を置いていることから、最大の市場シェアを占めると予想されます。さらに、ホルモン療法を求める高齢化社会と相まって、ホルモンバランスの乱れが蔓延していることも、市場の大幅な成長に寄与しています。好意的な償還政策と主要市場プレーヤーの存在が、北米市場の優位性をさらに強化しています。

CAGRが最も高い地域：

アジア太平洋地域は、更年期症状やホルモン障害に対する意識の高まりと相まって高齢化人口が拡大しているため、市場の力強い成長が見込まれています。さらに、急速な都市化、ライフスタイルの変化、ヘルスケアへの関心の高まりがホルモンバランスの乱れの有病率を高めており、市場の成長を後押ししています。さらに、ヘルスケアインフラの改善、可処分所得の増加、規制枠組みの進化が、アジア太平洋地域における実質的な成長を促進するために、より大きなアクセシビリティを容易にしています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

エストロゲンホルモン補充療法
ヒト成長ホルモン補充療法
エストロゲンホルモン補充療法
副甲状腺ホルモン補充療法
プロゲストーゲンホルモン補充療法
テストステロンホルモン補充療法
甲状腺ホルモン補充療法
その他の治療法

第6章世界のホルモン補充療法市場：投与経路別

経口
非経口
経皮
その他の投与経路

第7章世界のホルモン補充療法市場：適応症別

閉経
成長ホルモン欠乏症
甲状腺機能低下症
男性の性腺機能低下症
その他の適応症

第8章世界のホルモン補充療法市場：流通チャネル別

小売薬局およびドラッグストア
オンライン薬局
その他の流通チャネル

第9章世界のホルモン補充療法市場：地域別

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第11章企業プロファイル

AbbVie Inc.
Acerus Pharmaceuticals
Amgen
Bausch Health Companies
Bayer AG
Eli Lilly and Company
Merck & Co.
Mithra Pharmaceuticals SA
Mylan NV
Novartis AG
Novo Nordisk
Pfizer Inc.
QuatRx Pharmaceuticals
Radius Health
Sanofi
Serum Institute of India
Teva Pharmaceutical Industries
TherapeuticsMD
Veru Inc.

図表

List of Tables

Table 1 Global Hormone Replacement Therapy Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 3 Global Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 4 Global Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 5 Global Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 6 Global Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 7 Global Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 8 Global Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 9 Global Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 10 Global Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 11 Global Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 12 Global Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 13 Global Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 14 Global Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 15 Global Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 16 Global Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 17 Global Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 18 Global Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 19 Global Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 20 Global Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 21 Global Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 22 Global Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 23 Global Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 24 Global Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 25 Global Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 26 North America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
Table 27 North America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
Table 28 North America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 29 North America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 30 North America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 31 North America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 32 North America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 33 North America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 34 North America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 35 North America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 36 North America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 37 North America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 38 North America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 39 North America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 40 North America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 41 North America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 42 North America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 43 North America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 44 North America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 45 North America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 46 North America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 47 North America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 48 North America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 49 North America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 50 North America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 51 North America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 52 Europe Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
Table 53 Europe Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
Table 54 Europe Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 55 Europe Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 56 Europe Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 57 Europe Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 58 Europe Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 59 Europe Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 60 Europe Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 61 Europe Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 62 Europe Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 63 Europe Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 64 Europe Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 65 Europe Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 66 Europe Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 67 Europe Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 68 Europe Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 69 Europe Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 70 Europe Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 71 Europe Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 72 Europe Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 73 Europe Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 74 Europe Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 75 Europe Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 76 Europe Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 77 Europe Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 78 Asia Pacific Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
Table 79 Asia Pacific Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
Table 80 Asia Pacific Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 81 Asia Pacific Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 82 Asia Pacific Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 83 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 84 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 85 Asia Pacific Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 86 Asia Pacific Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 87 Asia Pacific Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 88 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 89 Asia Pacific Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 90 Asia Pacific Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 91 Asia Pacific Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 92 Asia Pacific Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 93 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 94 Asia Pacific Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 95 Asia Pacific Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 96 Asia Pacific Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 97 Asia Pacific Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 98 Asia Pacific Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 99 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 100 Asia Pacific Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 101 Asia Pacific Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 102 Asia Pacific Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 103 Asia Pacific Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 104 South America Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
Table 105 South America Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
Table 106 South America Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 107 South America Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 108 South America Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 109 South America Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 110 South America Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 111 South America Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 112 South America Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 113 South America Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 114 South America Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 115 South America Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 116 South America Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 117 South America Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 118 South America Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 119 South America Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 120 South America Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 121 South America Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 122 South America Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 123 South America Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 124 South America Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 125 South America Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 126 South America Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 127 South America Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 128 South America Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 129 South America Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Table 130 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Country (2021-2030) ($MN)
Table 131 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Product (2021-2030) ($MN)
Table 132 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 133 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Estrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 134 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Human Growth Hormone Replacement Therapy (2021-2030) ($MN)
Table 135 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oestrogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 136 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parathyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 137 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Progestogen Hormone Replacement Therapy (2021-2030) ($MN)
Table 138 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Testosterone Hormone Replacement Therapy (2021-2030) ($MN)
Table 139 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Thyroid Hormone Replacement Therapy (2021-2030) ($MN)
Table 140 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 141 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 142 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Oral (2021-2030) ($MN)
Table 143 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Parenteral (2021-2030) ($MN)
Table 144 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Transdermal (2021-2030) ($MN)
Table 145 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
Table 146 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Indication (2021-2030) ($MN)
Table 147 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Menopause (2021-2030) ($MN)
Table 148 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Growth Hormone Deficiency (2021-2030) ($MN)
Table 149 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 150 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Male Hypogonadism (2021-2030) ($MN)
Table 151 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
Table 152 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 153 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Retail Pharmacies and Drugstores (2021-2030) ($MN)
Table 154 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 155 Middle East & Africa Hormone Replacement Therapy Market Outlook, By Other Distribution Channels (2021-2030) ($MN)

Product Code: SMRC24489

According to Stratistics MRC, the Global Hormone Replacement Therapy Market is accounted for $35.8 billion in 2023 and is expected to reach $62.1 billion by 2030 growing at a CAGR of 8.2% during the forecast period. Hormone Replacement Therapy (HRT) involves medical treatments aimed at supplementing or replacing hormones, such as estrogen, progesterone, or testosterone, in individuals experiencing hormonal imbalances due to aging, menopause, or other conditions. HRT can alleviate symptoms like hot flashes, mood swings, and vaginal dryness in women and address hormonal deficiencies in men.

According to World Health Organization (WHO), it is estimated that by 2030, 1 in 6 people will be aged 60 years or more globally and by 2050, the geriatric population is expected to reach 2.1 billion worldwide.

Market Dynamics:

Driver:

Growing prevalence of various hormonal disorders

The increasing prevalence of diverse hormonal disorders serves as a significant driver in the hormone replacement therapy market. Factors such as aging populations, lifestyle changes, and environmental influences contribute to rising incidences of hormonal imbalances, menopause-related symptoms in women and andropause in men. Conditions like hypothyroidism, menopausal symptoms and hormonal deficiencies drive the demand for HRT. This growing patient pool seeking relief from symptoms and complications associated with hormonal disorders fuels the expansion of the hormone replacement therapy market.

Restraint:

High cost of hormone replacement therapy

Expenses for hormone replacement therapy medications, consultations and follow-up visits can be substantial, impacting affordability for many patients. Moreover, insurance coverage and reimbursement limitations often lead to out-of-pocket expenses, limiting accessibility. This financial barrier can deter individuals from seeking or continuing hormone replacement therapy, affecting treatment adherence and overall market growth.

Opportunity:

Rise in drug development with novel delivery systems

Innovative delivery methods, such as transdermal patches, subcutaneous implants and biodegradable microspheres, enhance treatment efficacy, patient compliance and convenience. These advancements offer precise dosing, steady hormone release and reduced side effects compared to traditional oral formulations. They also attract patient interest and expand treatment options, driving market growth by improving therapeutic outcomes and addressing the diverse needs of individuals seeking hormone replacement therapies.

Threat:

Adverse effects of therapies

Hormone therapies, particularly estrogen-based ones, may elevate the risk of blood clots, stroke, breast cancer and cardiovascular complications. These risks vary based on factors like age, dosage, duration of therapy, and individual health history. Concerns about these adverse effects have led to a decline in HRT usage and raised questions about its long-term safety, impacting market growth.

COVID-19 Impact:

The COVID-19 pandemic had varied impacts on the market. Disruptions in healthcare services, including limited access to clinics and reduced elective procedures, affected HRT prescriptions and patient consultations. Heightened health concerns led to delays in seeking hormonal therapies. However, increased awareness of menopausal symptoms and mental health issues during the pandemic might have driven demand for HRT.

The menopause segment is expected to be the largest during the forecast period

During the forecast period, the menopause segment is anticipated to become the largest in the market. As the population ages, the number of women entering menopause increases, leading to a larger demographic seeking therapies to manage menopausal symptoms like hot flashes, night sweats, and mood changes. Additionally, advancements in HRT formulations and delivery methods tailored specifically for menopausal symptoms contribute to the growth of this segment.

The human growth hormone replacement therapy segment is expected to have the highest CAGR during the forecast period

During the forecast period, the human growth hormone (HGH) replacement therapy segment is anticipated to experience robust growth owing to increased awareness of growth hormone deficiencies, coupled with rising instances of hormonal imbalances in adults and children, which is driving demand for HGH therapies. In addition, advancements in biotechnology, leading to the development of innovative HGH formulations and delivery methods, along with expanding applications in addressing various health conditions, are key contributors to the projected substantial growth in this segment.

Region with largest share:

North America is expected to witness the largest market share, due to the advanced healthcare infrastructure, high healthcare expenditure, and a significant emphasis on research and development. Moreover, the prevalence of hormonal imbalances, coupled with an aging population seeking hormone therapies, contributes to substantial market growth. Favorable reimbursement policies and the presence of key market players further reinforce North America's dominance in the market.

Region with highest CAGR:

Asia Pacific is poised for robust growth in the market due to the region's expanding aging population, coupled with increasing awareness of menopausal symptoms and hormonal disorders. Additionally, rapid urbanization, lifestyle changes, and a growing focus on healthcare have heightened the prevalence of hormonal imbalances, propelling market growth. Moreover, improving healthcare infrastructure, rising disposable incomes and evolving regulatory frameworks are facilitating greater accessibility to fostering substantial growth in the Asia Pacific region.

Key players in the market:

Some of the key players in Hormone Replacement Therapy Market include AbbVie Inc., Acerus Pharmaceuticals, Amgen, Bausch Health Companies, Bayer AG, Eli Lilly and Company, Merck & Co., Mithra Pharmaceuticals SA, Mylan NV, Novartis AG, Novo Nordisk, Pfizer Inc., QuatRx Pharmaceuticals, Radius Health, Sanofi, Serum Institute of India, Teva Pharmaceutical Industries, TherapeuticsMD and Veru Inc.

Key Developments:

In August 2022, Akorn announced that it had successfully received FDA approval for launching its Generic-Cetrorelix Acetate in the form of Injection (0.25 mg quantity). Cetrorelix is one of the most effective chemicals used in hormone replacement therapy as it totally blocks the adverse impacts of a natural hormone, known as GnRH or gonadotropin-releasing hormone.

In February 2022, MHLW of Japan approved NGENLA of Pfizer, Inc. and OPKO which is a long-lasting treatment for pediatric growth hormone deficiency. This strategic initiative helps the companies to expand their customer base in different geography and boost their revenue.

Therapy Types Covered:

Estrogen Hormone Replacement Therapy
Human Growth Hormone Replacement Therapy
Oestrogen Hormone Replacement Therapy
Parathyroid Hormone Replacement Therapy
Progestogen Hormone Replacement Therapy
Testosterone Hormone Replacement Therapy
Thyroid Hormone Replacement Therapy
Other Therapy Types

Route of Administrations Covered:

Oral
Parenteral
Transdermal
Other Route of Administrations

Indications Covered:

Menopause
Growth Hormone Deficiency
Hypothyroidism
Male Hypogonadism
Other Indications

Distribution Channels Covered:

Retail Pharmacies and Drugstores
Online Pharmacies
Other Distribution Channels

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Hormone Replacement Therapy Market, By Therapy Type

5.1 Introduction
5.2 Estrogen Hormone Replacement Therapy
5.3 Human Growth Hormone Replacement Therapy
5.4 Oestrogen Hormone Replacement Therapy
5.5 Parathyroid Hormone Replacement Therapy
5.6 Progestogen Hormone Replacement Therapy
5.7 Testosterone Hormone Replacement Therapy
5.8 Thyroid Hormone Replacement Therapy
5.9 Other Therapy Types

6 Global Hormone Replacement Therapy Market, By Route of Administration

6.1 Introduction
6.2 Oral
6.3 Parenteral
6.4 Transdermal
6.5 Other Route of Administrations

7 Global Hormone Replacement Therapy Market, By Indication

7.1 Introduction
7.2 Menopause
7.3 Growth Hormone Deficiency
7.4 Hypothyroidism
7.5 Male Hypogonadism
7.6 Other Indications

8 Global Hormone Replacement Therapy Market, By Distribution Channel

8.1 Introduction
8.2 Retail Pharmacies and Drugstores
8.3 Online Pharmacies
8.4 Other Distribution Channels

9 Global Hormone Replacement Therapy Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 AbbVie Inc.
11.2 Acerus Pharmaceuticals
11.3 Amgen
11.4 Bausch Health Companies
11.5 Bayer AG
11.6 Eli Lilly and Company
11.7 Merck & Co.
11.8 Mithra Pharmaceuticals SA
11.9 Mylan NV
11.10 Novartis AG
11.11 Novo Nordisk
11.12 Pfizer Inc.
11.13 QuatRx Pharmaceuticals
11.14 Radius Health
11.15 Sanofi
11.16 Serum Institute of India
11.17 Teva Pharmaceutical Industries
11.18 TherapeuticsMD
11.19 Veru Inc.